Skip to content

Cytek Biosciences, Inc. CTKB Payments For Taxes Related To Net Share Settlement Of Equity Awards

Payments For Taxes Related To Net Share Settlement Of Equity Awards at other companies

Advantage Solutions Inc. logo
Advantage Solutions Inc.ADV
$73K-89.7%
AerSale Corporation logo
AerSale CorporationASLE
$8K
GoodRx Holdings, Inc. logo
GoodRx Holdings, Inc.GDRX
$2.58M-31.3%
Synaptics logo
SynapticsSYNA
$17.8M+514%
Nutanix, Inc. logo
Nutanix, Inc.NTNX
$32.38M-50.0%
Wintrust Financial logo
Wintrust FinancialWTFC
$4.81M+60.3%

Other financials

Income statement

See full
Revenue$44.1M+6.5%
Gross profit$21.3M+5.4%
Operating income-$18.5M-23.3%
Net income-$18.9M-65.5%
EPS (diluted)-$0.15-66.7%

Balance sheet

See full
Cash & equivalents$31.8M-66.6%
Total debt$16.8M+40.9%
Total equity$327.6M-13.7%
Total assets$449.1M-6.9%

Cash flow

See full
Operating cash flow-$2.7M-2,089%
CapEx$2.2M+155%
Free cash flow-$4.9M-403%

Valuation

See full
Market cap$577.27M+54.5%
Enterprise value$562.23M+93.7%
P/S2.8×+0.9×

Profitability

See full
Gross margin51.7%-3.2pp
Operating margin-21.5%
Net margin-36.2%
FCF margin-6.2%-15.1pp

Returns & leverage

See full
Return on equity-20.9%
Debt / equity0.1×0.0×
Current ratio4.7×-0.9×

Where this comes from

Reported directly by Cytek Biosciences, Inc. in its filing.

Tagged under the XBRL concept ctkb:PaymentsForTaxesRelatedToNetShareSettlementOfEquityAwards.

The official record: Cytek Biosciences, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Cytek Biosciences, Inc.'s payments for taxes related to net share settlement of equity awards.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Cytek Biosciences, Inc.'s payments for taxes related to net share settlement of equity awards?
Cytek Biosciences, Inc. (CTKB) reported payments for taxes related to net share settlement of equity awards of $239K in Q1 2026.
How has Cytek Biosciences, Inc.'s payments for taxes related to net share settlement of equity awards changed year-over-year?
Cytek Biosciences, Inc.'s payments for taxes related to net share settlement of equity awards increased by 85.3% year-over-year, from $129K to $239K.
What is the long-term trend for Cytek Biosciences, Inc.'s payments for taxes related to net share settlement of equity awards?
Over 3 years (2022 to 2025), Cytek Biosciences, Inc.'s payments for taxes related to net share settlement of equity awards has grown at a 47.4% compound annual growth rate (CAGR), from $209K to $670K.
What does payments for taxes related to net share settlement of equity awards mean?
Measures the cash paid by the company to tax authorities to satisfy withholding obligations on behalf of employees during net share settlement of equity-based compensation. This is a recurring financing activity that impacts net cash flow available to shareholders.